Synonyms: | |
Status: | Approved (1989) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | P01BC02 |
UNII: | TML814419R |
InChI Key | XEEQGYMUWCZPDN-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C17H16F6N2O |
Molecular Weight | 378.32 |
AlogP | 4.45 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 2.0 |
Polar Surface Area | 45.15 |
Molecular species | BASE |
Aromatic Rings | 2.0 |
Heavy Atoms | 26.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Kinase
Protein Kinase
CMGC protein kinase group
CMGC protein kinase CDK family
|
- | 12000 | - | - | - | |
Ion channel
Ligand-gated ion channel
Glycine receptor
|
2500 | - | - | - | - | |
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 2600-5623 | - | - | 95 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 113 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Malaria | 4 | D008288 | ClinicalTrials |
Schistosomiasis haematobia | 3 | D012553 | ClinicalTrials |
Malaria, Falciparum | 3 | D016778 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Pneumonia, Viral | 2 | D011024 | ClinicalTrials |
Respiratory Insufficiency | 2 | D012131 | ClinicalTrials |
Gliosarcoma | 1 | D018316 | ClinicalTrials |
Leukoencephalopathy, Progressive Multifocal | 1 | D007968 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 53230-10-7 |
ChEBI | 63681 |
ChEMBL | CHEMBL416956 |
DrugBank | DB00358 |
FDA SRS | TML814419R |
Human Metabolome Database | HMDB0014502 |
Guide to Pharmacology | 4252 |
KEGG | C07633 |
PharmGKB | PA450348 |
PubChem | 40692 |
SureChEMBL | SCHEMBL21782 |